Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BORTEZOMIB Cause Type iii immune complex mediated reaction? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Type iii immune complex mediated reaction have been filed in association with BORTEZOMIB (bortezomib). This represents 0.0% of all adverse event reports for BORTEZOMIB.

16
Reports of Type iii immune complex mediated reaction with BORTEZOMIB
0.0%
of all BORTEZOMIB reports
16
Deaths
16
Hospitalizations

How Dangerous Is Type iii immune complex mediated reaction From BORTEZOMIB?

Of the 16 reports, 16 (100.0%) resulted in death, 16 (100.0%) required hospitalization.

Is Type iii immune complex mediated reaction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BORTEZOMIB. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does BORTEZOMIB Cause?

Plasma cell myeloma (6,683) Off label use (4,754) Neuropathy peripheral (4,067) Drug ineffective (2,730) Diarrhoea (2,244) Thrombocytopenia (2,082) Death (2,025) Pneumonia (2,020) Fatigue (1,757) Neutropenia (1,530)

What Other Drugs Cause Type iii immune complex mediated reaction?

RITUXIMAB (25) VANCOMYCIN (24) HUMAN IMMUNOGLOBULIN G (23) OXALIPLATIN (23) METHOTREXATE (19) MYCOPHENOLATE MOFETIL (18) TACROLIMUS (18) CYCLOPHOSPHAMIDE (17) CYCLOSPORINE (16) IMATINIB (16)

Which BORTEZOMIB Alternatives Have Lower Type iii immune complex mediated reaction Risk?

BORTEZOMIB vs BOSENTAN BORTEZOMIB vs BOSENTAN\BOSENTAN BORTEZOMIB vs BOSULIF BORTEZOMIB vs BOSUTINIB BORTEZOMIB vs BOTOX

Related Pages

BORTEZOMIB Full Profile All Type iii immune complex mediated reaction Reports All Drugs Causing Type iii immune complex mediated reaction BORTEZOMIB Demographics